FDA issues warning not to use specific COVID-19 test over risk of false results

The U.S. Food and Drug Administration has issued a safety communication warning people not to use the ACON Laboratories test named "Flowflex SARS-CoV-2 Antigen Rapid Test."

News 12 Staff

Mar 2, 2022, 12:05 PM

Updated 875 days ago

Share:

The U.S. Food and Drug Administration has issued a safety communication warning people not to use the ACON Laboratories test named "Flowflex SARS-CoV-2 Antigen Rapid Test."
The test is packaged in a dark blue box and has not been authorized, cleared, or approved by the FDA for distribution or use in the United States.
The FDA is concerned about the risk of false results when using this unauthorized test.
For more information, click HERE.


More from News 12